Lv4
500 积分 2021-06-15 加入
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
2天前
已完结
Use of dose-exposure-response relationships in Phase 2 and Phase 3 guselkumab studies to optimize dose selection in psoriasis
27天前
已完结
Artificial intelligence and machine learning for clinical pharmacology
1个月前
已完结
Integrating clinical pharmacology and artificial intelligence: potential benefits, challenges, and role of clinical pharmacologists
1个月前
已完结
Artificial Intelligence: From Buzzword to Useful Tool in Clinical Pharmacology
1个月前
已完结
Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune Thrombocytopenia
1个月前
已完结
Comparability of biosimilar romiplostim with originator: Protein characterization, animal pharmacodynamics and pharmacokinetics
1个月前
已完结
Statistical methodology for highly variable compounds: A novel design approach for the ofatumumab Phase 2 bioequivalence study
1个月前
已完结
ERα dysfunction caused by ESR1 mutations and therapeutic pressure promotes lineage plasticity in ER+ breast cancer
2个月前
已完结
Trilaciclib dosage in Chinese patients with extensive-stage small cell lung cancer: a pooled pharmacometrics analysis
2个月前
已完结
皖公网安备34019202002308
